PORTLAND, Oregon, October 5, 2016
PORTLAND, Oregon, October 5, 2016 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Pediatric Ultrasound Market for Cardiology -Global Opportunity Analysis andIndustry Forecast, 2014 -2022", the global revenue of pediatric ultrasound market for cardiology was $252 million in 2015 and is projected to reach $332 million by 2022, growing at a CAGR of 4% from 2016 to 2022. The adolescents (13-19 years) group led with one-fourth share of the overall market in 2015, and is expected to maintain its position throughout.
Summary of the Pediatric Ultrasound Market Report can be accessed on the website at https://www.alliedmarketresearch.com/ultrasound-market
The major factors boosting the market growth include technological advancements in ultrasound systems (such as 4D imaging capabilities incorporated in Vivid E95 cardiovascular ultrasound system), increase in incidence of cardiac diseases, and rise in public and private investments, grants, & funds for the development of more advanced ultrasound devices. In addition, increasing number of ultrasound diagnostic imaging procedures, rising demand for minimal invasive therapies, and growing awareness for early disease diagnosis are expected to drive the demand for pediatric cardiac ultrasound. Conversely, lack of skilled and experienced sonographers or pediatric cardiologists worldwide restrains the market growth.
The adolescents (aged 1319) segment accounted for the largest share of the market in 2015, and is anticipated to grow at a CAGR of 4.5% from 2016 to 2022. This is due to the inactive lifestyle and obesity, which causes acquired heart diseases in adolescents, thus resulting in high use of echocardiogram. An ultrasound procedure is generally preferred for children as there is no threat of exposure to ionizing radiation that may harm the tender body tissues (with repeated exposure) of infants.
Key findings of the pediatric ultrasound market study:
Europe was the second leading market, generating a market share of 27.7% in 2015, due to the high adoption rate of advanced technologies for diagnosis in European nations and high rate of heart diseases among adolescents owing to smoking, obesity, and physical inactivity.
The prominent players profiled in this report include Analogic Corporation, Esaote SpA, Fujifilm Corporation, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, Samsung Medison Co. Ltd., and Siemens Healthcare.
Summary of Similar Reports can be viewed at https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
SOURCE Allied Market ResearchPR Newswire
Last updated on: 05/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.